Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study

Summary Leucocyte counts of < 5 · 10 6 per blood transfusion product are currently recommended in the UK in order to reduce transfusion-related infections and febrile reactions. Routine leucocyte depletion, however, requires the development of reliable internal and external quality assurance (EQA) programmes. We report preliminary findings from the UK NEQAS for Low-Level Leucocyte Counting from 18 UK Transfusion Centres over a four month period. Data analysis showed that the IMAGN 2000 had the lowest CVs (range 7.5‐36%, mean 16.7) for samples with counts of 5‐30 cells/ll when compared to the flow cytometric (range 13.8‐88%, mean 29.5) and Nageotte methods (range 20.6‐117%, mean 61.8). In addition, laboratories using commercial nuclear stains (LeucoCOUNT TM ) had consistently lower CVs than those using ‘in-house’ propidium iodide staining methods. Important differences in flow cytometric gating strategies were also identified. This study highlights the current variability in low level leucocyte counting, especially within the critical range of 5‐30 cells/ll (equating to < 5 · 10 6 /l). The acceptance of consensus protocols, including gating strategies and nuclear staining techniques, is required to reduce the observed interlaboratory variation. Finally, we demonstrate that stabilized blood preparations can be successfully used to provide a national/international low-level leucocyte EQA scheme.